Oratox Liquid
NDC Package 43742-0944-1
Package Information
Oratox (fucus vesiculosus, lymph node (suis), medulla ossis suis, thymus (suis), thyroidinum (suis), calcarea muriatica, iodium, natrum fluoratum, natrum muriaticum, selenium metallicum, vanadium metallicum, argentum metallicum, aurum metallicum, cuprum metallicum, eugenol, formalinum, lidocaine, mercurius solubilis, molybdenum metallicum, niccolum metallicum, palladium metallicum, stannum metallicum, titanium metallicum, zincum metallicum) liquids is for temporary relief of symptoms related to heavy metal toxicity caused by toxic dental materials in the mouth. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-0944.
Identification & Billing
Clinical Specifications
- CALCIUM CHLORIDE 12 [hp_X]/mL
- COPPER 12 [hp_X]/mL
- EUGENOL 12 [hp_X]/mL
- FORMALDEHYDE 12 [hp_X]/mL
- FUCUS VESICULOSUS 3 [hp_X]/mL
- GOLD 12 [hp_X]/mL
- IODINE 12 [hp_X]/mL
- LIDOCAINE 12 [hp_X]/mL
- MERCURIUS SOLUBILIS 12 [hp_X]/mL
- MOLYBDENUM 12 [hp_X]/mL
- NICKEL 12 [hp_X]/mL
- PALLADIUM 12 [hp_X]/mL
- SELENIUM 12 [hp_X]/mL
- SILVER 12 [hp_X]/mL
- SODIUM CHLORIDE 12 [hp_X]/mL
- SODIUM FLUORIDE 12 [hp_X]/mL
- SUS SCROFA BONE MARROW 8 [hp_X]/mL
- SUS SCROFA LYMPH 8 [hp_X]/mL
- SUS SCROFA THYMUS 8 [hp_X]/mL
- THYROID 8 [hp_X]/mL
- TIN 12 [hp_X]/mL
- TITANIUM 12 [hp_X]/mL
- VANADIUM 12 [hp_X]/mL
- ZINC 12 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Local Anesthesia - [PE] (Physiologic Effect)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-0944 - Oratox
- 43742-0944-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-0944 - Oratox
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-0944-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Oratox, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains calcium chloride; copper; eugenol; formaldehyde; fucus vesiculosus; gold; iodine; lidocaine; mercurius solubilis; molybdenum; nickel; palladium; selenium; silver; sodium chloride; sodium fluoride; sus scrofa bone marrow; sus scrofa lymph; sus scrofa thymus; thyroid; tin; titanium; vanadium; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on December 27, 2016. The current certification is valid through December 31, 2026.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742094401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.